Publication | Closed Access

Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure

CardiomyopathyHeart FailureCardiovascular DiseasePlasminogen ActivatorsMedicineAtherosclerosisPhysiologyVascular BiologyCardiac FailurePharmacologyTherapeutic AngiogenesisCardiologyExtracellular MatrixCardiac Pathology